ResearcherMayo ClinicNo recent work listed

Xiangyu Zeng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4913-3704; OpenAlex author ID A5043543046. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 1 paper

Papers 1

METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43018-022-00429-3 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhenkun Lou · 1 shared paper, 2022 · strength 0.10
- Paper METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic d… DOI 10.1038/s43018-022-00429-3 ↗
Yu Shi · 1 shared paper, 2022 · strength 0.10
- Paper METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic d… DOI 10.1038/s43018-022-00429-3 ↗
Kaixiong Tao · 1 shared paper, 2022 · strength 0.10
- Paper METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic d… DOI 10.1038/s43018-022-00429-3 ↗
Min Deng · 1 shared paper, 2022 · strength 0.10
- Paper METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic d… DOI 10.1038/s43018-022-00429-3 ↗
Zhijie Xu · 1 shared paper, 2022 · strength 0.10
- Paper METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic d… DOI 10.1038/s43018-022-00429-3 ↗
Xinyi Tu · 1 shared paper, 2022 · strength 0.10
- Paper METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic d… DOI 10.1038/s43018-022-00429-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.